The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Complications After Prostate Biopsy: Data From SEER-Medicare
Open accessAbstract
PURPOSE: More than 1 million prostate biopsies are performed annually among Medicare beneficiaries. We determined the risk of serious complications requiring hospitalization. We hypothesized that with emerging multidrug resistant organisms there may be an increasing risk of infectious complications. MATERIALS AND METHODS: In a 5% random sample of Medicare participants in SEER (Surveillance, Epidemiology and End Results) regions from 1991 to 2007 we compared 30-day hospitalization rates and ICD-9 primary diagnosis codes for admissions between 17,472 men who underwent prostate biopsy and a random sample of 134,977 controls. Multivariate logistic and Poisson regression were used to examine the risk and predictors of serious infectious and noninfectious complications with time. RESULTS: The 30-day hospitalization rate was 6.9% within 30 days of prostate biopsy, which was substantially higher than the 2.7% in the control population. After adjusting for age, race, SEER region, year and comorbidities prostate biopsy was associated with a 2.65-fold (95% CI 2.47-2.84) increased risk of hospitalization within 30 days compared to the control population (p <0.0001). The risk of infectious complications requiring hospitalization after biopsy was significantly greater in more recent years (p(trend) = 0.001). Among men undergoing biopsy, later year, nonwhite race and higher comorbidity scores were significantly associated with an increased risk of infectious complications. CONCLUSIONS: The risk of hospitalization within 30 days of prostate biopsy was significantly higher than in a control population. Infectious complications after prostate biopsy have increased in recent years while the rate of serious noninfectious complications is relatively stable. Careful patient selection for prostate biopsy is essential to minimize the potential harms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis
Wolf, J. S., Bennett, C. J., Dmochowski, R. R., Hollenbeck, B. K., Pearle, M. S., & Schaeffer, A. J. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.01.068 · Cited by 901
Nam, R. K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L. H., Loblaw, D. A., Trachtenberg, J., Stanimirovic, A., Simor, A. E., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.015 · Cited by 592
Human Health Consequences of Use of Antimicrobial Agents in Aquaculture
Heuer, O. E., Kruse, H., Grave, K., Collignon, P., Karunasagar, I., & Angulo, F. J. (2009) · Clinical Infectious Diseases · doi:10.1086/605667 · Cited by 533
Rodríguez, L. V., & Terris, M. K. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62255-9 · Cited by 406
Identification of In-Hospital Complications From Claims Data: Is It Valid?
Lawthers, A. G., McCarthy, E. P., Davis, R. B., Peterson, L. E., Palmer, R. H., & Iezzoni, L. I. (2000) · Medical Care · doi:10.1097/00005650-200008000-00003 · Cited by 402
Nam, R. K., Saskin, R., Lee, Y., Liu, Y., Law, C., Klotz, L. H., Loblaw, D. A., Trachtenberg, J., Stanimirovic, A., Simor, A. E., et al. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.11.043 · Cited by 402
ZHANEL, G., HISANAGA, T., LAING, N., DECORBY, M., NICHOL, K., WESHNOWESKI, B., JOHNSON, J., NOREDDIN, A., LOW, D., & KARLOWSKY, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.009 · Cited by 302
Zhanel, G. G., Hisanaga, T. L., Laing, N. M., DeCorby, M. R., Nichol, K. A., Palatnick, L. P., Johnson, J., Noreddin, A., Harding, G. K. M., Nicolle, L. E., et al. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.08.003 · Cited by 235
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Pitout, J. D. D. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02089.x · Cited by 222
Peralta, G., Sanchez, M. B., Garrido, J. C., De Benito, I., Cano, M. E., Martinez-Martinez, L., & Roiz, M. P. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm279 · Cited by 207
Detection of Prostate Cancer via Biopsy in the Medicare-SEER Population During the PSA Era
Welch, H. G., Fisher, E. S., Gottlieb, D. J., & Barry, M. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm119 · Cited by 179
Roberts, R. R., Scott, R. D., Hota, B., Kampe, L. M., Abbasi, F., Schabowski, S., Ahmad, I., Ciavarella, G. G., Cordell, R., Solomon, S. L., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181ef60a2 · Cited by 167
Goossens‐Laan, C. A., Gooiker, G. A., van Gijn, W., Post, P. N., Bosch, J. L. H. R., Kil, P. J. M., & Wouters, M. W. J. M. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.037 · Cited by 139
Al‐Hasan, M. N., Lahr, B. D., Eckel-Passow, J. E., & Baddour, L. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp162 · Cited by 125
Agabiti, N., Cesaroni, G., Picciotto, S., Bisanti, L., Caranci, N., Costa, G., Forastiere, F., Marinacci, C., Pandolfi, P., Russo, A. G., et al. (2008) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2007.067470 · Cited by 75
Mortality at 120 days after prostatic biopsy: A population‐based study of 22,175 men
Andrea Gallina, A., Suardi, N. R., Montorsi, F., Umberto Capitanio, A., Claudio Jeldres, A., Fred Saad, C., Graefen, M., Shariat, S. F., Widmer, H., Arjane, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23559 · Cited by 54
Antimicrobial Resistance Trends of Escherichia coli Bloodstream Isolates: A Population-Based Study
Al‐Hasan, M. N. (2008) · Cited by 20
Cited by
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.09.046 · Cited by 1,936
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Prostate-Cancer Mortality at 11 Years of Follow-up
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113135 · Cited by 1,245
Early Detection of Prostate Cancer: AUA Guideline
Carter, H. B., Albertsen, P. C., Barry, M. J., Etzioni, R., Freedland, S. J., Greene, K. L., Holmberg, L., Kantoff, P., Konety, B. R., Murad, M. H., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.04.119 · Cited by 1,242
Self-citation
Metadata
- Authors
- Loeb, S., Carter, H. B., Berndt, S. I., Ricker, W., & Schaeffer, E. M.
- Venue
- Journal of Urology
- Published
- 2011-11
- Volume
- 186
- Issue
- 5
- Pages
- 1830-1834
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2057615180
- Cited by
- 685
- References
- 22
- FWCI
- 47.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.